Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Firms Dig In Against Baucus Fee, Despite Class I, Revenue Exceptions

This article was originally published in The Gray Sheet

Executive Summary

The device industry lobbying machine has accelerated in opposition to Sen. Max Baucus' plan for a $40 billion fee on manufacturers in the lead up to Finance Committee health reform mark-up sessions this week

You may also be interested in...



With Device Tax Seeming Inevitable, Groups Align On Small-Firm Protections

Groups representing the device industry have aligned to push an amendment to the Senate health care reform bill to exempt more pre- and low-profit companies from the proposed $20 billion device tax

With Device Tax Seeming Inevitable, Groups Align On Small-Firm Protections

Groups representing the device industry have aligned to push an amendment to the Senate health care reform bill to exempt more pre- and low-profit companies from the proposed $20 billion device tax

Finance Dems Block Move To Strip Device Fee, But Signal Room To Negotiate

An amendment that would have stripped a proposed $4 billion annual fee on device manufacturers from health care reform legislation was voted down by Senate Finance Committee Democrats Oct. 1, but they signaled an interest to negotiate further

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027930

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel